Fundz

Uk-Based Online Employee Health Record Solution Secures £2.25M Funding From Boost&Co

Oct 08, 2021

Amount Raised

£2.25 Million

Round Type

Seed

BiotechnologyData And AnalyticsHealth Care

Description

Medical Management Systems (MMS), the company behind UK’s leading online employee health record solution, Meddbase, has secured a £2.25 million investment from BOOST&Co, an alternative lender.

Quick answer

MMS raised £2.25 Million in a Seed round, dated October 8, 2021.

How much did MMS raise?
MMS raised £2.25 Million in a Seed round on October 8, 2021.
What does MMS do?
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory..
Where is MMS based and how big is it?
Fundz records about 950 employees.
Who are the decision-makers at MMS?
Fundz holds 1 contact at MMS. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Data And Analytics and Biotechnology around the same time

Companies in the same sectors as MMS that raised within 45 days of this round, from Fundz verified event records.

  • Cardurion Pharmaceuticals raised an undisclosed amount on October 27, 2021.
  • American Bitcoin raised $18M on October 20, 2021.
  • Envisagenics raised $19M on October 19, 2021.
  • Exscientia raised $510M (Post-IPO Equity) on October 5, 2021.
  • Envisagenics raised an undisclosed amount (Series A) on September 29, 2021.
  • Delix Therapeutics raised $70M (Series A) on September 27, 2021.

Who to call at MMS, and when

A new round usually means MMS is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MMS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MMS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MMS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MMS

About

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MMS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MMS's next move

See what Strategic adds

MMS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.